Literature DB >> 20490313

Superoxide anion, uncoupling proteins and Alzheimer's disease.

Zhaofei Wu1, Yan Zhao, Baolu Zhao.   

Abstract

Superoxide anion is the first generated reactive oxygen species (ROS) after oxygen enters living cells. It was once considered to be highly deleterious to cell functions and aging. Therefore, antioxidants were suggested to prevent aging and degenerative diseases. However, superoxide signaling has been shown in many physiological responses such as transcriptional regulation, protein activation, bioenergy output, cell proliferation and apoptosis. The uncoupling proteins (UCPs) are a family of mitochondrial anion-carrier proteins located in the inner mitochondrial membrane and are considered to reduce the generation of superoxide anion through the mitochondrial mild uncoupling. UCPs are important in prevention of mitochondrial excessive generation of ROS, transfer of mitochondrial substrates, mitochondrial calcium uniport and regulation of thermogenesis. Superoxide anion and uncoupling proteins are linked to Alzheimer's disease in mitochondria. Simultaneous disorders of superoxide and uncoupling proteins create the conditions for neuronal oxidative damages. On the one hand, sustained oxidative damage causes neuronal apoptosis and eventually, accumulated neuronal apoptosis, leading to exacerbations of Alzheimer's disease. On the other hand, our study has shown that UCP2 and UCP4 have important impact on mitochondrial calcium concentration of nerve cells, suggesting that their abnormal expression may involve in the pathogenesis of Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; neurodegeneration; oxidative stress; superoxide anion; uncoupling protein

Year:  2010        PMID: 20490313      PMCID: PMC2872223          DOI: 10.3164/jcbn.09-104-2

Source DB:  PubMed          Journal:  J Clin Biochem Nutr        ISSN: 0912-0009            Impact factor:   3.114


Introduction

Supoxide anion (O2•−) is the first free radical of all reactive oxygen species (ROS) generated in vivo. Mitochondrial respiratory chain is one of the main places where O2•− is produced [1]. A large number of studies have shown that O2•− can initiate a variety of oxidative damage responses to phospholipids, proteins and nucleic acids by generating many kinds of oxygen free radicals, causing degenerative diseases and aging [2]. Recently, it is found that the uncoupling proteins embedded in mitochondrial inner membrane are important molecules for the regulation of O2•− generation and protecting cells from oxidative damage [3]. Meanwhile, there’s a growing body of evidence to suggest that O2•− has important physiological functions in vivo, not only the culprit of cellular oxidative damage. It puts forward a theoretical challenge to the traditional concept of treating degenerative diseases and aging by using antioxidants to remove superoxide. This review will focus on the physiological functions of O2•− and uncoupling proteins, and try to discuss their roles in the pathogenesis of Alzheimer’s disease.

Physiological Functions of O2•−

Contrary to the once prevalent concept that O2•− is highly deleterious to cell function and healthy aging, at present, an important role of superoxide signaling has been discovered in a variety of physiological responses such as transcriptional activation, bioenergy output, cell proliferation, and apoptosis [4].

Transcriptional activation

New developments of superoxide anion participation in enzymatic phosphorylation/dephosphorylation reactions are of particular interest. These processes are mainly related to protein kinase cascade. Baas and Berk have found that O2•− activated mitogen-activated protein kinases (MAPK) in vascular smooth muscle cells by a way different from H2O2 in 1995 [5]. Huang et al. suggested that the peroxisome proliferator activated receptor-γ (PPAR-γ) agonists stimulation of extracellular signal-related protein kinase (EPK) phosphorylation in murine myoblasts was mediated by O2•− [6]. It was found that mitochondrial superoxide modulated nuclear cAMP-responsive element-binding protein (CREB) phosphorylation in hippocampal neurons [7]. The activity of the important nuclear transcription factor NFκB is regulated by O2•− formation. NFκB is maintained in the cytosol in an inactive form bound to the inhibitor IκBα. Following plasma membrane superoxide and H2O2 formation, induced by various cell effectors (e.g. cytokines, hormones), and regulated by Ras 1 (G protein), a transduction protein phosphokinase acts to phosphorylate IκBα. This phosphorylation results in dissociation of the complex, IκBα-P ubiquitination and its destruction by the proteasome, and release of NFκB to translocate to the nucleus and function as a major transcription regulator [8]. Interestingly, recent evidence appears to directly implicate Na+/H+ transporter 1 (NHE1), which is strongly suggested as a key molecule in redox-mediated cell fate decisions, as a downstream target of intracellular ROS such that an increase in intracellular O2•− stimulates NHE1 promoter activity and gene expression [9].

Cell differentiation and proliferation

There is a growing literature on normally produced extracellular effectors determining the intracellular redox state of cells and consequently in some instances the course of cellular self-propagation or differentiation. As shown by Smith et al., an intracellular redox environment induced to favour a more oxidized state by thyroid hormone or bone morphogenic protein 4 leads to a differentiation of the precursor cells into oligodendrocytes or astrocytes. On the other hand, an intracellular redox environment induced to favour a more reducing state by basic fibroblast growth factor or platelet-derived growth factor promotes self-propagation of the precursor cells [10]. A substantial body of data support the involvement of low levels of O2•− in proliferative signaling. Increased, nontoxic O2•− levels achieved by downregulation of SOD with antisense oligonucleotides inhibited apoptosis, whereas over-expression of SOD or inhibition of NAD(P)H oxidase led to a decrease in O2•− and increased susceptibility of cells to undergo apoptosis [11]. Mild elevation in intracellular O2•− stimulates growth responses in a variety of cell types via activation of early growth-related genes such as c-fos and c-jun, alterations in the activities of protein kinases, oxidative inactivation of phosphatases, and activation of transcription factors [12, 13]. It seems that O2•− can serve as a growth signal in different cells via a rac/ras-NAD(P)H oxidase-MAPK signaling pathway [13]. Oberley et al. showed that overexpression of the oncogenic form of the small G protein v-Ha-ras increased O2•− generation and the growth of the human keratinocyte cell line HaCaT. In contrast, overexpression of virally transduced SOD blocked the growth-stimulatory effect of v-Ha-ras overexpression, suggesting that intracellular O2•− was responsible for this effect. In addition to the keratinocyte cell line, rat kidney epithelial cells could also be stimulated to grow and form colonies in soft agar in an O2•−-dependent manner by v-Ha-ras overexpression [14]. A few studies also suggested the involvement of O2•− in differentiation signaling. Wang et al. have reported that O2•− can promote osteogenic differentiation of mesenchymal stem cells using animal and cell models [15]. Lately, reduced expression of the NADPH oxidase NOX4 was suggested as a hallmark of adipocyte differentiation. Data suggest an appealing scenario where in preadipocytes an initial insulin-induced “burst” in superoxide production may trigger signaling events leading to the initialization of the adipocyte differentiation process and eventually to the downregulation of NOX4 and the upregulation of insulin receptor expression [16].

Immunoprotection

T cell activation during an immune response is strongly augmented in the presence of O2•− or at relatively low concentrations of H2O2 via ROS dependent increase in IL-2 promoter activity and transcription and surface expression of the IL-2 receptor [17]. Macrophage plasma membrane NADPH oxidase is a potent source of very high concentrations of O2•− and hydrogen peroxide (mM) employed for the killing of sequestrated pathogen [18]. Moreover, recent findings suggest that ROS generated from the NADPH oxidase complex contribute to monocyte/macrophage survival [19].

Regulation of energy metabolism- Ca2+ regulating messenger

Wu and de Champlain have shown that superoxide enhanced the hydrolysis of phosphatidylinositol (PIP) to inositol 1,4,5-tris-phosphate (IP3) in rat aortic smooth muscle cells [20]. The regulation of calmodulin (CM) function by O2•−/hydrogen peroxide oxidation of specific methionine residues is now well-documented [21]. The oxidation of methionine residues at positions 144 and 145 of CM is involved in down regulation of plasma membrane (PM) Ca2+ ATPase activity [22]. It has also been reported from the same laboratory that methionine sulfoxide reductase can act reductively to restore the ability of oxidized CM to regulate PM–Ca2+ ATPase [23]. These results indicate that O2•−/hydrogen peroxide functions as part of the controlled regulation of the CM–PM–Ca2+ ATPase complex. The regulated prooxidant formation of the O2•−/H2O2 second messenger system is essential for the normal physiological function of the metabolome. The normally functioning metabolome is the expression of a dynamic equilibrium comprised of thousands of anabolic and catabolic reactions, which are finely tuned by signaling systems. There is still much to be learnt about the up/down regulation of these messenger systems. The concept that O2•−/H2O2 causes random macromolecular damage should be discussed according to the specific cellular environment. Thus, the administration of antioxidants to quench the inferred toxicity of these compounds as a therapy for age associated diseases should be subjected to serious evaluation and needs to be supported by results from animal models and clinical trials [24].

Inhibition of apoptosis

Recent findings have demonstrated that a mild increase in intracellular superoxide inhibited apoptosis in tumor cells, irrespective of the trigger [25]. The discovery of the death inhibitory activity of intracellular O2•− has challenged the dogmatic view that ROS are deleterious to cell growth and survival. It appears that a permissive intracellular environment for apoptotic signaling is a function of a tight balance between intracellular O2•− and H2O2, and that a decrease in intracellular O2•− or a reciprocal increase in H2O2 facilitates apoptotic execution [26]. Earlier data implicated Rac-dependent increase in intracellular O2•− in the mitogenic signaling that is induced upon the activation of Ras [27]. As shown by Pervaiz et al., expression of a constitutively active form of Rac1 in human melanoma cells (M14) resulted in a mild increase in intracellular O2•− with a concomitant decrease in the sensitivity of tumor cells to apoptosis [28].

Regulation of protein activity and protein turnover

One of the established effects of O2•− in signaling is the activation of the ras/rac-Raf1-MAPK pathway [29]. Angiotensin II (ANG II) induces O2•− generation in endothelial cells via the ubiquitous NAD(P)H oxidase. This O2•− then activates the Raf-1-MAPK pathway, leading to altered gene expression. ANG II has also been shown to stimulate O2•− production in the central nervous system to increase vasopressin secretion and sympathetic outflow. This was confirmed in vivo as adenoviral vector-mediated expression of SOD (AdSOD) in mice blocked both ANG II-induced O2•− generation and changes in blood pressure, heart rate, and drinking behavior. Huang et al. recently demonstrated that ERK activation induced by PPAR-γ agonists was blocked by a SOD mimetic and induced by an O2•−-generating system, representing another example that O2•− affecting protein activity [6]. Moreover, as previously described, O2•− can activate nuclear transcription factor NFκB [8]. Obviously, protein activation is an important function of O2•−. Conventionally, protein modifications by ROS and reactive nitrogen species (RNS) are considered as random and highly undesirable, leading to protein malfunction. In turn, these modified proteins must be removed by proteasome-catalyzed degradation. However, contrary to this concept, current viewpoints suggest that NO/peroxynitrite and O2•−/H2O2 do not simply randomly damage proteins, instead, they play important roles in the regulated proteolysis and homeostasis of proteins. One example of protein degradation promoted by O2•− as mentioned above is the regulation of calmodulin activity [21, 22]. In addition, O2•− continually formed in small amounts during the oxidation of hemoglobin (Hb) to met Hb in the order of a steady state amount of 1–3%. The met Hb formed is continually reduced back to Hb by erythrocyte met Hb reductase to maintain oxygen homeostasis [18]. It suggests that the production of superoxide anion related to the body’s oxygen supply.

Physiological Functions of Uncoupling Proteins

The UCPs are a family of mitochondrial anion-carrier proteins that are located on the inner mitochondrial membrane. The UCP superfamily comprises integral membrane proteins that share structural and functional similarities. A common feature is a tripartite structure, with three repeats of ~100 amino acids, each containing two hydrophobic stretches that correspond to transmembrane alpha helices. The two transmembrane helices in each repeat are linked by a long hydrophilic loop, which is orientated towards the matrix side of the membrane, and the amino and carboxyl termini of UCP extend into the intermembrane space. Interestingly, anion carriers and channel proteins most frequently rely on the formation of alpha-helical stretches with 12 membrane-spanning regions, and the functional unit of UCPs is a homodimer formed by two identical subunits that contain 12 transmembrane helices. Therefore, although UCP4 and BMCP1 are divergent in amino acid sequence compared with UCP1, they share a common protein structure with UCP1–3, which underlies functional anion-carrier proteins. Mitochondrial uncoupling mediated by UCP1 is classically associated with non-shivering thermogenesis by brown fat. Recent evidence indicates that UCP family proteins are also present in selected neurons. Notably, UCP4 and BMCP1 (also known as UCP5) have been shown to be highly expressed in the central nervous system. Unlike UCP1, these proteins (UCP2, UCP4 and BMCP1/UCP5) are not constitutive uncouplers and are not crucial for the non-shivering thermogenesis. However, they can be activated by free radicals and free fatty acids, and their activity has a profound influence on neuronal functions [30]. Except for UCP1, the precise physiological functions of UCPs have not yet been established. Following are several viewpoints about the physiological functions of UCPs.

Regulation of ROS production

UCPs are thought to be responsible for an inducible, mild uncoupling of mitochondria that may be able to prevent excessive mitochondrial ROS production [3, 31]. A lot of articles support this view, but it is hard to tell whether regulation of ROS production is the main function of UCPs or just the side effect of the main function.

Transportation of mitochondrial substrates

UCP3 expressed in glycolytic muscle fibres may be a passive pyruvate transporter ensuring equilibrium between glycolysis and oxidative phosphorylation. Induction of UCP2 expression by glutamine strengthens the hypothesis that newly discovered UCPs could act to determine the choice of mitochondrial substrate [31].

Calcium regulation

Mitochondria have evolved as important cytosolic calcium buffers. Since calcium cannot be metabolized like other second-messenger molecules, intracellular calcium must be tightly regulated to maintain homeostasis. UCP2 and UCP3 were reported to be fundamentally involved in mitochondrial Ca2+ uniport, the process that represents the main pathway sequestrating Ca2+ into the mitochondrial matrix [32]. UCP4, a neuronal UCP, was also reported to regulate cellular Ca2+ homeostasis [33]. As mitochondria are enriched in presynaptic terminals, and the calcium milieu of axon terminals is important in vesicle traffic, fusion, release and recycling, regulation of presynaptic calcium concentrations by UCPs is expected to affect neurotransmission directly [30]. Our study shows that UCP2 and UCP4 have an important impact on mitochondrial calcium concentration of nerve cells, suggesting that their abnormal expression may be involved in the pathogenesis of AD [34].

Thermogenesis in microenvironments

CNS areas rich in UCPs (such as the hypothalamus) have a higher local temperature than areas relatively devoid of UCPs (for example, the striatum and thalamus, which have a 2.7% reduction compared with the hypothalamus), despite steady core body temperature. Recent evidence indicates that temperature gradients created by neuronal UCPs enhance the migration of chemical signals from a cell source to high-affinity receptors on cells for the signal, especially in brain regions where there are mismatches in innervation and receptor localization [35]. In short, by regulating mitochondrial biogenesis, calcium flux, free radical production and local temperature, neuronal UCPs can directly influence neurotransmission, synaptic plasticity and neurodegenerative processes. Insights into the regulation and function of these proteins offer unsuspected avenues for a better understanding of synaptic transmission and neurodegeneration [30].

The Roles of O2•− and Uncoupling Proteins in the Pathogenesis of Alzheimer’s Disease

Alzheimer’s disease affects almost 2% of the population in industrialized countries and the risk is significantly increased in individuals of more than 70 years of age. It is characterized by neurofibrillary tangle formation in neuronal perikarya and extracellular deposits of amyloid-β protein [36]. Unfortunately, up to date we still have no effective cure for this disease. The studies over the past one hundred years haven’t given a complete answer for its etiology and pathogenesis. Therefore, according to new research data to explore the etiology and pathogenesis of AD from different perspectives is necessary.

The roles of O2•− in the pathogenesis of AD

There is extensive literature supporting a role of oxidative damage in the pathogenesis of AD and oxidative damage probably contribute causally to AD-related pathology [2]. Oxidative damage occurs early in the AD brain, before the onset of significant plaque pathology. Oxidative damage also precedes Aβ deposition in transgenic APP mice, with up-regulation of genes relating to mitochondrial metabolism and apoptosis occurring even earlier and co-localizing with the neurons undergoing oxidative damage. In a transgenic APP-mutant mouse, hemizygous deficiency of the mitochondrial antioxidant enzyme MnSOD markedly increased brain Aβ levels and plaque deposition [37]. O2•− is the precursor of many other ROS, thus its production may initiate the oxidative damage seen in AD brain. Several cell signaling pathways linking oxidative stress and AD pathology have been uncovered recently. Specifically, oxidative stress may activate signaling pathways that alter APP or tau processing. For example, oxidative stress increases the expression of β-secretase through activation of c-Jun amino-terminal kinase and p38 MAPK, and increases aberrant tau phosphorylation by activation of glycogen synthase kinase 3 [38]. Oxidant-induced inactivation of critical molecules may also be important. In a proteomic study, the prolyl isomerase PIN1 was found to be particularly sensitive to oxidative damage. PIN1 catalyses protein conformational changes that affect both APP and tau processing. Knockout of Pin1 increases amyloidogenic APP processing and intracellular Aβ levels in mice [39]. PIN1-knockout mice also exhibit tau hyperphosphorylation, motor and behavioural deficits, and neuronal degeneration [40]. Therefore, oxidative stress may lead to AD-related pathological changes by inactivating PIN1. AD was associated with significantly increased expression of the p53 pro-apoptosis gene, all 3 isoforms of nitric oxide synthase (NOS 1-3), and NOX 1 and NOX 3, beginning early in the course of disease. Activation of cyto-protective mechanisms in AD brains is limited since the expression of uncoupling protein 2, 4, and 5, and PPAR alpha and delta genes is significantly reduced, whereas PPAR-gamma expression is selectively increased. The results demonstrate that AD is associated with early and striking increases in the molecular indices of oxidative stress. The simultaneous reductions in cyto-protective mechanisms (UCP and PPAR), could allow oxidative injury to go unchecked and persist or increase over time. Adopting strategies to reduce the effects of NOS and NOX activities, and improve the actions of UCPs and PPARs may help in the treatment of AD [41]. Notably, mitochondrion is the bridge to link together O2•−, UCPs and AD. Converging evidences suggest that most of the proteins implicated in AD pathogenesis have direct physical involvement with mitochondria or mitochondrial proteins. APP has been found to have a dual endoplasmic reticulum/mitochondrial-targeting sequence, and in cells and transgenic mice overexpressing APP it clogged the mitochondrial protein importation machinery, causing mitochondrial dysfunction and impaired energy metabolism [42]. Aβ binds to a mitochondrial-matrix protein termed Aβ-binding alcohol dehydrogenase (ABAD). Blocking the interaction of Aβ and ABAD with a ‘decoy peptide’ suppressed Aβ-induced apoptosis and free-radical generation in neurons. Conversely, overexpression of ABAD in transgenic APP-mutant mice exaggerated neuronal oxidative stress and impaired memory [43]. Two other groups have also reported that Aβ interacts with mitochondria, inhibiting cytochrome oxidase activity and increasing free-radical generation [44]. Aβ also inhibits α-ketoglutarate dehydrogenase activity in isolated mitochondria, and deficiency of α-ketoglutarate dehydrogenase and cytochrome oxidase activities has previously been observed in the brain and other tissues in AD [45]. Aβ also interacts with the serine protease HTRA2 (also known as OMI) [46]. Presenilin and all the other components of the γ-secretase complex have also been localized to mitochondria, where they form an active γ-secretase complex [47]. It should be noted that most cells possess enzymatic systems that are capable of producing O2•−, whereas to date no cellular system is known to exclusively generate H2O2. In most cases, the first reaction of O2 is the one-electron reduction O2•−. Although many biological effects have been ascribed to H2O2 and have been extensively discussed elsewhere, the insight starts to emerge that O2•− may be a more important mediator of cellular effects [12].

The roles of UCPs in the pathogenesis of AD

As mentioned above, once the expression levels of UCP 2, 4, 5 were significantly decreased, the ability of neurons from AD brain to be protected from oxidative stress damage was impaired. The impairment of the cell self-protection mechanism (UCPs and PPARs) makes it possible for the oxidative damage to persist unrestrictedly, even exacerbate over time. Intriguingly, O2•− themselves can induce the expression of UCPs, including UCP2 and UCP4 [34], and activate proton transport through UCP1–3 [48]. Moreover, products of oxidative stress, such as 4-hydroxy-2-nonenal, may also regulate mitochondrial uncoupling [49]. Therefore, ROS-induced uncoupling might act as a simple feedback mechanism to limit the extent of oxidative cell damage, which could lead to protection against neurodegenerative diseases and ageing. Tangles and plaques are found predominantly in areas of AD brain that regulate learning, memory and emotional behaviours, including the hippocampus, cortex, basal forebrain and brain stem. Interestingly, these brain regions also express neuronal UCPs. Although there are no studies directly linking neuronal uncoupling activity to Alzheimer’s disease, neuronal UCPs might regulate many of the pathogenic mechanisms that lead to neuronal degeneration, such as increased oxidative damage, perturbed cellular calcium homeostasis, impaired energy metabolism and synaptic dysfunction [36]. Indeed, UCP4 modulates neuronal energy metabolism by increasing glucose uptake and shifting the mode of ATP production from mitochondrial respiration to glycolysis, thereby maintaining cellular ATP levels [50], and abnormalities in glucose regulation and insulin resistance are risk factors for Alzheimer’s disease [51]. Furthermore, dietary restriction, which protects neurons from dysfunction and death in models of Alzheimer’s disease [36], also enhances UCP4 expression in the cortex and hippocampus [52]. Our study shows that UCP2 and UCP4 modulate mitochondrial calcium concentration of nerve cells, and can be regulated by O2•−, suggesting that this dysfunction of mitochondrial calcium may be involved in the pathogenesis of AD [34].

Concluding Remarks

In summary, O2•− is an oxygen free radical with important physiological functions in vivo; UCPs are proteins with important physiological functions in vivo. O2•− is like a sharp double-edged sword, on the one hand, activating gene transcription, promoting cell growth and proliferation and inhibiting apoptosis, on the other hand, leading to oxidative stress, causing apoptosis. Neuronal UCPs can resist oxidative stress or maintain the calcium regulation capability of mitochondria to play a role in preventing the neurodegeneration of Alzheimer’s disease. Simultaneous disorders of O2•− and uncoupling proteins create the conditions for the neuronal oxidative damage. Sustained oxidative damage can further cause neuronal apoptosis and eventually, extended neuronal death, leading to exacerbations of Alzheimer’s disease. Block oxidative damage and balance of free radicals generation may inhibit neuronal apoptosis and eventually prevent and cure Alzheimer’s disease.
  51 in total

1.  Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

2.  Brain uncoupling protein 2: uncoupled neuronal mitochondria predict thermal synapses in homeostatic centers.

Authors:  T L Horvath; C H Warden; M Hajos; A Lombardi; F Goglia; S Diano
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

3.  Superoxide activates mitochondrial uncoupling proteins.

Authors:  Karim S Echtay; Damien Roussel; Julie St-Pierre; Mika B Jekabsons; Susana Cadenas; Jeff A Stuart; James A Harper; Stephen J Roebuck; Alastair Morrison; Susan Pickering; John C Clapham; Martin D Brand
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

4.  Nonessential role for methionines in the productive association between calmodulin and the plasma membrane Ca-ATPase.

Authors:  D Yin; H Sun; R F Weaver; T C Squier
Journal:  Biochemistry       Date:  1999-10-12       Impact factor: 3.162

Review 5.  Ras, superoxide and signal transduction.

Authors:  K Irani; P J Goldschmidt-Clermont
Journal:  Biochem Pharmacol       Date:  1998-05-01       Impact factor: 5.858

Review 6.  Mitochondrial uncoupling proteins in the CNS: in support of function and survival.

Authors:  Zane B Andrews; Sabrina Diano; Tamas L Horvath
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

7.  Reduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation.

Authors:  Sarah Mouche; Sanae Ben Mkaddem; Wei Wang; Masa Katic; Yu-Hua Tseng; Stephanie Carnesecchi; Klaus Steger; Michelangelo Foti; Christoph A Meier; Patrick Muzzin; C Ronald Kahn; Eric Ogier-Denis; Ildiko Szanto
Journal:  Biochim Biophys Acta       Date:  2007-03-19

8.  Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.

Authors:  Wan-Chen Huang; Chung-Ching Chio; Kwan-Hwa Chi; Hsiao-Mei Wu; Wan-Wan Lin
Journal:  Exp Cell Res       Date:  2002-07-15       Impact factor: 3.905

Review 9.  Role of NADPH oxidases in the control of vascular gene expression.

Authors:  Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2003-12       Impact factor: 8.401

10.  Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi.

Authors:  Hyo-Jin Park; Young-Mo Seong; Ju-Youn Choi; Seongman Kang; Hyangshuk Rhim
Journal:  Neurosci Lett       Date:  2004-02-26       Impact factor: 3.046

View more
  20 in total

Review 1.  Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.

Authors:  Yanwei Li; Lin Li; Christian Hölscher
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

Review 2.  Antioxidants in Down syndrome.

Authors:  Ira T Lott
Journal:  Biochim Biophys Acta       Date:  2011-12-21

3.  Chemical Diversity and Biological Activity of African Propolis.

Authors:  Natalia Blicharska; Veronique Seidel
Journal:  Prog Chem Org Nat Prod       Date:  2019

4.  Microchip electrophoresis with laser-induced fluorescence detection for the determination of the ratio of nitric oxide to superoxide production in macrophages during inflammation.

Authors:  Giuseppe Caruso; Claudia G Fresta; Joseph M Siegel; Manjula B Wijesinghe; Susan M Lunte
Journal:  Anal Bioanal Chem       Date:  2017-05-29       Impact factor: 4.142

5.  Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system.

Authors:  Manisha Nautiyal; Prasad V G Katakam; David W Busija; Patricia E Gallagher; E Ann Tallant; Mark C Chappell; Debra I Diz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-22       Impact factor: 3.619

6.  Antioxidant enzymes and oxidative stress in the erythrocytes of iron deficiency anemic patients supplemented with vitamins.

Authors:  Nirjala Laxmi Madhikarmi; Kora Rudraiah Siddalinga Murthy
Journal:  Iran Biomed J       Date:  2014

7.  Inhibition of ROS-induced apoptosis in endothelial cells by nitrone spin traps via induction of phase II enzymes and suppression of mitochondria-dependent pro-apoptotic signaling.

Authors:  Amlan Das; Bhavani Gopalakrishnan; Oliver H Voss; Andrea I Doseff; Frederick A Villamena
Journal:  Biochem Pharmacol       Date:  2012-05-10       Impact factor: 5.858

8.  Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease.

Authors:  Philip Wl Ho; Jessica Wm Ho; Hui-Fang Liu; Danny Hf So; Zero Hm Tse; Koon-Ho Chan; David B Ramsden; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2012-01-13       Impact factor: 8.014

9.  Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).

Authors:  Andrea Cossarizza; Hyun-Dong Chang; Andreas Radbruch; Andreas Acs; Dieter Adam; Sabine Adam-Klages; William W Agace; Nima Aghaeepour; Mübeccel Akdis; Matthieu Allez; Larissa Nogueira Almeida; Giorgia Alvisi; Graham Anderson; Immanuel Andrä; Francesco Annunziato; Achille Anselmo; Petra Bacher; Cosima T Baldari; Sudipto Bari; Vincenzo Barnaba; Joana Barros-Martins; Luca Battistini; Wolfgang Bauer; Sabine Baumgart; Nicole Baumgarth; Dirk Baumjohann; Bianka Baying; Mary Bebawy; Burkhard Becher; Wolfgang Beisker; Vladimir Benes; Rudi Beyaert; Alfonso Blanco; Dominic A Boardman; Christian Bogdan; Jessica G Borger; Giovanna Borsellino; Philip E Boulais; Jolene A Bradford; Dirk Brenner; Ryan R Brinkman; Anna E S Brooks; Dirk H Busch; Martin Büscher; Timothy P Bushnell; Federica Calzetti; Garth Cameron; Ilenia Cammarata; Xuetao Cao; Susanna L Cardell; Stefano Casola; Marco A Cassatella; Andrea Cavani; Antonio Celada; Lucienne Chatenoud; Pratip K Chattopadhyay; Sue Chow; Eleni Christakou; Luka Čičin-Šain; Mario Clerici; Federico S Colombo; Laura Cook; Anne Cooke; Andrea M Cooper; Alexandra J Corbett; Antonio Cosma; Lorenzo Cosmi; Pierre G Coulie; Ana Cumano; Ljiljana Cvetkovic; Van Duc Dang; Chantip Dang-Heine; Martin S Davey; Derek Davies; Sara De Biasi; Genny Del Zotto; Gelo Victoriano Dela Cruz; Michael Delacher; Silvia Della Bella; Paolo Dellabona; Günnur Deniz; Mark Dessing; James P Di Santo; Andreas Diefenbach; Francesco Dieli; Andreas Dolf; Thomas Dörner; Regine J Dress; Diana Dudziak; Michael Dustin; Charles-Antoine Dutertre; Friederike Ebner; Sidonia B G Eckle; Matthias Edinger; Pascale Eede; Götz R A Ehrhardt; Marcus Eich; Pablo Engel; Britta Engelhardt; Anna Erdei; Charlotte Esser; Bart Everts; Maximilien Evrard; Christine S Falk; Todd A Fehniger; Mar Felipo-Benavent; Helen Ferry; Markus Feuerer; Andrew Filby; Kata Filkor; Simon Fillatreau; Marie Follo; Irmgard Förster; John Foster; Gemma A Foulds; Britta Frehse; Paul S Frenette; Stefan Frischbutter; Wolfgang Fritzsche; David W Galbraith; Anastasia Gangaev; Natalio Garbi; Brice Gaudilliere; Ricardo T Gazzinelli; Jens Geginat; Wilhelm Gerner; Nicholas A Gherardin; Kamran Ghoreschi; Lara Gibellini; Florent Ginhoux; Keisuke Goda; Dale I Godfrey; Christoph Goettlinger; Jose M González-Navajas; Carl S Goodyear; Andrea Gori; Jane L Grogan; Daryl Grummitt; Andreas Grützkau; Claudia Haftmann; Jonas Hahn; Hamida Hammad; Günter Hämmerling; Leo Hansmann; Goran Hansson; Christopher M Harpur; Susanne Hartmann; Andrea Hauser; Anja E Hauser; David L Haviland; David Hedley; Daniela C Hernández; Guadalupe Herrera; Martin Herrmann; Christoph Hess; Thomas Höfer; Petra Hoffmann; Kristin Hogquist; Tristan Holland; Thomas Höllt; Rikard Holmdahl; Pleun Hombrink; Jessica P Houston; Bimba F Hoyer; Bo Huang; Fang-Ping Huang; Johanna E Huber; Jochen Huehn; Michael Hundemer; Christopher A Hunter; William Y K Hwang; Anna Iannone; Florian Ingelfinger; Sabine M Ivison; Hans-Martin Jäck; Peter K Jani; Beatriz Jávega; Stipan Jonjic; Toralf Kaiser; Tomas Kalina; Thomas Kamradt; Stefan H E Kaufmann; Baerbel Keller; Steven L C Ketelaars; Ahad Khalilnezhad; Srijit Khan; Jan Kisielow; Paul Klenerman; Jasmin Knopf; Hui-Fern Koay; Katja Kobow; Jay K Kolls; Wan Ting Kong; Manfred Kopf; Thomas Korn; Katharina Kriegsmann; Hendy Kristyanto; Thomas Kroneis; Andreas Krueger; Jenny Kühne; Christian Kukat; Désirée Kunkel; Heike Kunze-Schumacher; Tomohiro Kurosaki; Christian Kurts; Pia Kvistborg; Immanuel Kwok; Jonathan Landry; Olivier Lantz; Paola Lanuti; Francesca LaRosa; Agnès Lehuen; Salomé LeibundGut-Landmann; Michael D Leipold; Leslie Y T Leung; Megan K Levings; Andreia C Lino; Francesco Liotta; Virginia Litwin; Yanling Liu; Hans-Gustaf Ljunggren; Michael Lohoff; Giovanna Lombardi; Lilly Lopez; Miguel López-Botet; Amy E Lovett-Racke; Erik Lubberts; Herve Luche; Burkhard Ludewig; Enrico Lugli; Sebastian Lunemann; Holden T Maecker; Laura Maggi; Orla Maguire; Florian Mair; Kerstin H Mair; Alberto Mantovani; Rudolf A Manz; Aaron J Marshall; Alicia Martínez-Romero; Glòria Martrus; Ivana Marventano; Wlodzimierz Maslinski; Giuseppe Matarese; Anna Vittoria Mattioli; Christian Maueröder; Alessio Mazzoni; James McCluskey; Mairi McGrath; Helen M McGuire; Iain B McInnes; Henrik E Mei; Fritz Melchers; Susanne Melzer; Dirk Mielenz; Stephen D Miller; Kingston H G Mills; Hans Minderman; Jenny Mjösberg; Jonni Moore; Barry Moran; Lorenzo Moretta; Tim R Mosmann; Susann Müller; Gabriele Multhoff; Luis Enrique Muñoz; Christian Münz; Toshinori Nakayama; Milena Nasi; Katrin Neumann; Lai Guan Ng; Antonia Niedobitek; Sussan Nourshargh; Gabriel Núñez; José-Enrique O'Connor; Aaron Ochel; Anna Oja; Diana Ordonez; Alberto Orfao; Eva Orlowski-Oliver; Wenjun Ouyang; Annette Oxenius; Raghavendra Palankar; Isabel Panse; Kovit Pattanapanyasat; Malte Paulsen; Dinko Pavlinic; Livius Penter; Pärt Peterson; Christian Peth; Jordi Petriz; Federica Piancone; Winfried F Pickl; Silvia Piconese; Marcello Pinti; A Graham Pockley; Malgorzata Justyna Podolska; Zhiyong Poon; Katharina Pracht; Immo Prinz; Carlo E M Pucillo; Sally A Quataert; Linda Quatrini; Kylie M Quinn; Helena Radbruch; Tim R D J Radstake; Susann Rahmig; Hans-Peter Rahn; Bartek Rajwa; Gevitha Ravichandran; Yotam Raz; Jonathan A Rebhahn; Diether Recktenwald; Dorothea Reimer; Caetano Reis e Sousa; Ester B M Remmerswaal; Lisa Richter; Laura G Rico; Andy Riddell; Aja M Rieger; J Paul Robinson; Chiara Romagnani; Anna Rubartelli; Jürgen Ruland; Armin Saalmüller; Yvan Saeys; Takashi Saito; Shimon Sakaguchi; Francisco Sala-de-Oyanguren; Yvonne Samstag; Sharon Sanderson; Inga Sandrock; Angela Santoni; Ramon Bellmàs Sanz; Marina Saresella; Catherine Sautes-Fridman; Birgit Sawitzki; Linda Schadt; Alexander Scheffold; Hans U Scherer; Matthias Schiemann; Frank A Schildberg; Esther Schimisky; Andreas Schlitzer; Josephine Schlosser; Stephan Schmid; Steffen Schmitt; Kilian Schober; Daniel Schraivogel; Wolfgang Schuh; Thomas Schüler; Reiner Schulte; Axel Ronald Schulz; Sebastian R Schulz; Cristiano Scottá; Daniel Scott-Algara; David P Sester; T Vincent Shankey; Bruno Silva-Santos; Anna Katharina Simon; Katarzyna M Sitnik; Silvano Sozzani; Daniel E Speiser; Josef Spidlen; Anders Stahlberg; Alan M Stall; Natalie Stanley; Regina Stark; Christina Stehle; Tobit Steinmetz; Hannes Stockinger; Yousuke Takahama; Kiyoshi Takeda; Leonard Tan; Attila Tárnok; Gisa Tiegs; Gergely Toldi; Julia Tornack; Elisabetta Traggiai; Mohamed Trebak; Timothy I M Tree; Joe Trotter; John Trowsdale; Maria Tsoumakidou; Henning Ulrich; Sophia Urbanczyk; Willem van de Veen; Maries van den Broek; Edwin van der Pol; Sofie Van Gassen; Gert Van Isterdael; René A W van Lier; Marc Veldhoen; Salvador Vento-Asturias; Paulo Vieira; David Voehringer; Hans-Dieter Volk; Anouk von Borstel; Konrad von Volkmann; Ari Waisman; Rachael V Walker; Paul K Wallace; Sa A Wang; Xin M Wang; Michael D Ward; Kirsten A Ward-Hartstonge; Klaus Warnatz; Gary Warnes; Sarah Warth; Claudia Waskow; James V Watson; Carsten Watzl; Leonie Wegener; Thomas Weisenburger; Annika Wiedemann; Jürgen Wienands; Anneke Wilharm; Robert John Wilkinson; Gerald Willimsky; James B Wing; Rieke Winkelmann; Thomas H Winkler; Oliver F Wirz; Alicia Wong; Peter Wurst; Jennie H M Yang; Juhao Yang; Maria Yazdanbakhsh; Liping Yu; Alice Yue; Hanlin Zhang; Yi Zhao; Susanne Maria Ziegler; Christina Zielinski; Jakob Zimmermann; Arturo Zychlinsky
Journal:  Eur J Immunol       Date:  2019-10       Impact factor: 6.688

Review 10.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.